Cargando…

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma

BACKGROUND: The World Health Organization (WHO) recommends annual mass azithromycin distribution until districts drop below 5% prevalence of trachomatous inflammation—follicular (TF). Districts with very low TF prevalence may have little or no transmission of the ocular strains of Chlamydia trachoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amza, Abdou, Kadri, Boubacar, Nassirou, Beido, Arzika, Ahmed M., Austin, Ariana, Nyatigo, Fanice, Lebas, Elodie, Arnold, Benjamin F., Lietman, Thomas M., Oldenburg, Catherine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789605/ https://www.ncbi.nlm.nih.gov/pubmed/33407263 http://dx.doi.org/10.1186/s12886-020-01776-4

Ejemplares similares

Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021)

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger
por: Kim, Jessica S., et al.
Publicado: (2019)

Application of smartphone cameras for detecting clinically active trachoma
por: Bhosai, Satasuk Joy, et al.
Publicado: (2012)

Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Elimination of Active Trachoma after Two Topical Mass Treatments with Azithromycin 1.5% Eye Drops
por: Amza, Abdou, et al.
Publicado: (2010)

Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021)

Optimal Seasonal Timing of Oral Azithromycin for Malaria
por: Gao, Daozhou, et al.
Publicado: (2014)

Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023)

Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023)

Neonatal azithromycin administration for prevention of infant mortality
por: Oldenburg, Catherine E., et al.
Publicado: (2022)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2015)

Erratum to: Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2016)

Reliability of Trachoma Clinical Grading—Assessing Grading of Marginal Cases
por: Rahman, Salman A., et al.
Publicado: (2014)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws
por: Marks, Michael, et al.
Publicado: (2015)

Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
por: Hu, Huiyu, et al.
Publicado: (2022)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Effect of Neonatal Azithromycin on All-Cause and Cause-Specific Infant Mortality: A Randomized Controlled Trial
por: Sié, Ali, et al.
Publicado: (2022)

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
por: Harrison, Mark Andrew, et al.
Publicado: (2019)

Effectiveness and safety of azithromycin 1.5% eye drops for mass treatment of active trachoma in a highly endemic district in Cameroon
por: Bella, Assumpta Lucienne, et al.
Publicado: (2020)

Prevalence of Trachoma at Sub-District Level in Ethiopia: Determining When to Stop Mass Azithromycin Distribution
por: King, Jonathan D., et al.
Publicado: (2014)

Using model-based geostatistics for assessing the elimination of trachoma
por: Sasanami, Misaki, et al.
Publicado: (2023)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma
por: Ho, Derek K-H., et al.
Publicado: (2015)

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

Can we eradicate trachoma? A survey of stakeholders
por: Oldenburg, Catherine E, et al.
Publicado: (2021)

Neonatal Azithromycin Administration and Growth during Infancy: A Randomized Controlled Trial
por: Sie, Ali, et al.
Publicado: (2023)

Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial
por: Brogdon, Jessica, et al.
Publicado: (2022)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

Exploring water, sanitation, and hygiene coverage targets for reaching and sustaining trachoma elimination: G-computation analysis
por: Sullivan, Kristin M., et al.
Publicado: (2023)

Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx
por: Gladstone, Rebecca A., et al.
Publicado: (2021)

Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities
por: Wilson, Nana, et al.
Publicado: (2018)

Effectiveness of azithromycin mass drug administration on trachoma: a systematic review
por: Xiong, Tao, et al.
Publicado: (2021)

Infant mortality and growth failure after oral azithromycin among low birthweight and underweight neonates: A subgroup analysis of a randomized controlled trial
por: Bountogo, Mamadou, et al.
Publicado: (2023)

Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia
por: Burr, Sarah E., et al.
Publicado: (2013)

Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qe614tv9fd9jd3hmjaiov3kaki